Fundraising Fox

Forge Biologics

Grove City, US · Delaware LLC · 3 known investors

forgebiologics.com ↗

Forge Biologics provides contract manufacturing and process development for AAV-based gene therapies, operating a large-scale cGMP facility with proprietary manufacturing technologies to support developers from early discovery through commercial production.

Advanced ManufacturingBiotechMedical Devicesin /forge-biologics@forgebio

Founders & leadership

CG
Chris GarabedianDirector
MM
Molly McCartinDirector
TJ
Timothy J. MillerExecutive Officer, Director

Investors · 3

Aisling CapitalNew York
Drive CapitalColumbus · $5M – $30Mvia Molly Bonakdarpour · board
RA CapitalBoston

Reported raises · per SEC filings

Form D private placements
▶$120MraisedMay 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick CalloriDirector
  • Timothy J. MillerExecutive Officer, Director
  • Molly BonakdarpourDirector
  • Matthew HammondDirector
  • Chris GarabedianDirector
Offering amount
$120M
Amount sold
$120M
Sales commissions
$4.3M
First sale
Apr 2021
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedAug 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris GarabedianDirector
  • Molly McCartinDirector
  • Timothy J. MillerExecutive Officer, Director
Offering amount
$40M
Amount sold
$40M
First sale
Jul 2020
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.